2025 Guidance -- First quarter GMV forecasted at $90 million to $96 million (down 2% to up 5%), net revenue at $21.7 million ...
Discusses HOPE-3 Phase III Trial Results and Regulatory Path for Duchenne Muscular Dystrophy Therapy December 17, ...
Goldman Sachs Industrials and Materials Conference 2025 December 4, 2025 8:00 AM ESTCompany ParticipantsWilliam Brown - CEO ...
Scleroderma is a rare autoimmune disease involving an overproduction of the protein collagen. Linear scleroderma usually begins as a streak of hardened, waxy, discolored skin on the forehead, an arm, ...
This study presents a valuable advance in reconstructing naturalistic speech from intracranial ECoG data using a dual-pathway model. The evidence supporting the claims of the authors is solid, ...
Association of paleopalynological data from the Nanxiong Basin, south China, and late Paleocene niche expansion in endemic Asian fossil mammals.
Dr. JeFreda R. Brown is a financial consultant, Certified Financial Education Instructor, and researcher who has assisted thousands of clients over a more than two-decade career. She is the CEO of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results